KRAS vaccine

KRAS-targeted cancer vaccine · Sichuan University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KRAS vaccine, covering 2025-06-24 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer [Phase 2]

See pricing